Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head

HPB

Volumn 15, Issue 9, 2013, Pages 716-723

  Denost, Quentin ^a,b   Laurent, Christophe ^b   Adam, Jean Philippe ^a,b   Capdepont, Maylis ^b   Vendrely, Veronique ^a,b   Collet, Denis ^a   Sa Cunha, Antonio ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREATIC HEAD ADENOCARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CHEMORADIOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882451036     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12039     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130.
2. Black RJ, Bray F, Ferlay J, Parkin DM,. (1997) Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33: 1075-1107.
3. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW,. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91: 586-594.
4. White RR, Reddy S, Tyler DS,. (2005) The role of chemoradiation therapy in locally advanced pancreatic cancer. HPB 7: 109-113.
5. Sa Cunha A, Rault A, Laurent C, Adhoute X, Vendrely V, Bellannee G, et al. (2005) Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg 201: 359-365.
6. White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, et al. (1999) Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6: 38-45.
7. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, et al. (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 135: 81-87.
8. Turrini O, Viret F, Moureau-Zabotto L, Guiramand J, Moutardier V, Lelong B, et al. (2009) Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma. Eur J Surg Oncol 35: 1306-1311.
9. Callery MP, Chang KJ, Fishman EK, Talamonti MS, Traverso LW, Linehan DC,. (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16: 1727-1733.
10. International Commission on Radiation Units and Measurements. (1993) Prescribing, recording and reporting photo beam therapy. ICRU report 50: Bethesda, MD. International Commission on Radiation Units and Measurements.
11. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, et al. (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumour Study Group. Cancer 48: 1705-1710.
12. Gastrointestinal Tumour Study Group. (1988) Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80: 751-755.
13. Huguet F, Andre T, Hammel P, Artru P, Balosso J, Selle F, et al. (2007) Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25: 326-331.
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. (2000) New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
15. Bonnichon P, Rossat-Mignod JC, Corlieu P, Aaron C, Yandza T, Chapuis Y,. (1987) Surgical approach to the superior mesenteric artery by the Kocher manoeuvre: anatomy study and clinical applications. Ann Vasc Surg 1: 505-508.
16. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213.
17. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138: 8-13.
18. Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L,. (2000) Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 89: 314-327.
19. Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, et al. (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern Cooperative Oncology Group Trial. J Clin Oncol 29: 4105-4112.
20. Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, Andre T, et al. (2005) Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 23: 3509-3516.
21. Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, et al. (2003) Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 7: 766-772.
22. Morganti AG, Massaccesi M, La Torre G, Caravatta L, Piscopo A, Tambaro R, et al. (2010) A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 17: 194-205.
23. Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, et al. (2006) Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol 13: 1201-1208.
24. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15: 1651-1660.
25. Verbeke CS,. (2008) Resection margins and R1 rates in pancreatic cancer-are we there yet? Histopathology 52: 787-796.
26. van den Broeck A, Sergeant G, Ectors N, van Steenbergen W, Aerts R, Topal B,. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35: 600-604.
27. Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, et al. (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8: 123-132.
28. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236: 355-366.
29. Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW, et al. (2004) Pylorus-preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicentre analysis of 170 patients with pancreatic and periampullary tumours. Ann Surg 240: 738-745.
30. Golcher H, Brunner T, Grabenbauer G, Merkel S, Papadopoulos T, Hohenberger W, et al. (2008) Preoperative chemoradiation in adenocarcinoma of the pancreas. A single-centre experience advocating a new treatment strategy. Eur J Surg Oncol 34: 756-764.
31. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S,. (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21: 195-200.
32. Maire F, Sauvanet A, Trivin F, Hammel P, O'Toole D, Palazzo L, et al. (2004) Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: an indirect evaluation of the usefulness of laparoscopy. Pancreatology 4: 436-440.
33. Barbier L, Turrini O, Gregoire E, Viret F, Le Treut YP, Delpero JR,. (2011) Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival. HPB 13: 64-69.